Yuanyuan Wu
3PUBLICATIONS
4CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (3)
Sort by Publication Date:
|Dec 04, 2024
Co-treatment with erythropoietin derived HBSP and caspase-3 siRNA: A promising approach to prevent fibrosis after acute kidney injury.Yuanyuan Wu, Yanan Wang, Fei Chen
|Nov 25, 2024
HBSP inhibits tubular cell pyroptosis and apoptosis, promotes macrophage M2 polarization, and protects LPS-induced acute kidney injury.Lili Huang, Yuanyuan Wu, Wenli Sai
|Aug 08, 2020
Potent Therapy and Transcriptional Profile of Combined Erythropoietin-Derived Peptide Cyclic Helix B Surface Peptide and Caspase-3 siRNA against Kidney Ischemia/Reperfusion Injury in Mice.Yuanyuan Wu, Weiwei Chen, Yufang Zhang
Pageof 1

